DRESSING, CHEST SEAL

The contract provides for the procurement of a twin-pack chest seal dressing designed for the emergency treatment of penetrating chest wounds, featuring three-channel pressure relief vents that prevent air from entering the chest cavity during inhalation while allowing air and blood to escape during exhalation. Each seal deploys to a 6-inch by 6-inch size and includes a large red-tip tab for single-step peel-and-apply application, enabling immediate wound burping if needed. The dressing is packaged in a foil wrapper with tear-notches and perforated packaging to allow for controlled, single-unit access in field conditions. The product must maintain a 60-month shelf life with no more than nine months elapsed between the manufacturer’s date and delivery to the government, in strict compliance with MMS1A shelf-life marking standards. All packaging must include the manufacturer date, expiration or retest date, contract number, and lot number, and meet MIL-STD-129 labeling requirements with machine-readable barcodes. The item is classified as a Type I (Code S) shelf-life item under RS023 and must comply with DLA packaging standards RP001 and technical requirements from the DLA Master List. The delivery is scheduled for 20 days after order placement to a designated location in Raleigh, North Carolina, under FOB destination terms, meaning title and risk transfer to the government upon delivery. Inspection and acceptance occur at the destination by government personnel, with compliance verified against FAR, DFARS, ASTM D3951, and FED-STD-313 standards. The contract mandates adherence to numerous federal acquisition regulations, including clauses on employment equity, trafficking prevention, cybersecurity safeguarding, hazardous material labeling, and whistleblower protections, with specific requirements for compliance with NIST SP 800-171 and safeguarding covered defense information. Offerors must hold a valid UEI and CAGE code and provide complete representations regarding small business status, joint venture participation, and compliance with federal prohibitions on covered telecommunications equipment. All submissions are required via the DIBBS portal by the deadline of May 19, 2026, and payment will be processed solely through WAWF using electronic invoicing methods. The item, identified by NSN 6510-01-642-6212, is a Class I medical device exempt from premarket notification under FDA 21 CFR 878.4020 and must carry manufacturer-specific part and source information as specified by